Safety, Efficacy and Sensory Evaluation of Serum in Conferring facial skin Anti- ageing benefits in Healthy Human Volunteers.

ITC LIMITED0 个研究点目标入组 47 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Indian/Asian female subjects
•2. Healthy subjects between 35 and 60 years of age.
•3. Skin in healthy state on the studied anatomic site (free of eczema, wounds, cuts, bruises,
•inflammatory scar).
•4. Mild to moderate wrinkles in the crow's feet area and/or nasolabial area and/or forehead
•5. Subjects who have not undergone any facial or anti-ageing procedures (e.g., Botulinum
•toxin, dermal filler injections, laser resurfacing) in the past 3 months.
•6.Subject should be willing to abstain from spa treatments/facials during the study period.
•7. Subjects willing to abide by the study protocol and restriction (refrain from using any product
•other than provided investigational product (IP)).

•1.Subjects who are pregnant or nursing (as confirmed by Urine pregnancy test for the
•determination of Pregnancy) or planning to conceive in coming 4-5 months.
•2. Subjects with a present condition of allergic response to any cosmetic product.
•3. Subjects undergoing treatment for any skin care concern.
•4. Subjects under chronic medication (e.g., aspirin-based products, anti-inflammatories,
•antihistamines etc.) that might influence the outcome of the study.
•5. Subjects who has used any systemic medication (antibiotics, oral contraceptive pills, steroids,
•or any other anti-acne medication) or any topical facial medication with in past 4 weeks.
•6. Having acne of severe incidence (presence of Nodules, Cysts or numerous pustules) which
•requires pharmaceutical treatment.
•7. Subjects with excessive facial hair or scars on test sites (face and volar forearm), which could
•interfere with evaluation.
•8. Subjects having cutaneous hypersensitivity.

发起方